Skip to main content

Advertisement

Log in

Metabolic syndrome in chronic kidney disease and renal transplant patients in North India

  • Nephrology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Aim

The cluster of biochemical and clinical abnormalities known as metabolic syndrome (MS) has become a public health problem even in developing countries. Previous studies have shown a graded relationship between MS components and worsening renal function in the general population. The prevalence of MS in non-dialysis-dependent CKD (NDD-CKD) and kidney transplant recipients in the North Indian population is unknown.

Methods

We studied all patients with stable CKD and with renal transplantation attending the nephrology clinic in a large centre in North India over an eight-week period. All transplant patients had stable graft function for 3 months prior to recruitment. MS was defined according to the International Diabetes Federation (IDF) 2007 guidelines. A total of 252 (155 NDD-CKD and 97 renal transplant recipients) patients were studied.

Results

MS was present in 86 (34%) patients. The prevalence of MS was similar in NDD-CKD and transplant patients [60 (39%) vs. 26 (27%), P = 0.052]. Patients with MS were older than those wihout MS (48 ± 12 years-old vs. 40 ± 14 years-old, P < 0.001) and MS was more common in women than in men (59% vs. 26%, P < 0.001). Female gender was an independent risk factor for MS in this population [adjusted OR 5.25 (95% CI: 2.74–10.06)]. With advancing CKD, the prevalence of MS decreased in the NDD-CKD patients. Impaired glucose tolerance and hypertriglyceridemia were independent predictors of MS. Hypertension was not a predictor of MS in NDD-CKD. In transplant recipients, hypertriglyceridemia, hypertension and low HDL cholesterol predicted the risk for MS.

Conclusion

MS is common in CKD and renal transplant patients in North India. The risk of MS decreases with declining eGFR in CKD patients. Female gender and hypertriglyceridemia independently predict the risk of MS in both NDD-CKD and transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS (2003) Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41:1–12

    Article  PubMed  Google Scholar 

  2. Stevens PE, O’Donoghue DJ, Ls de, Van VJ, Klebe B, Middleton DJ et al (2007) Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 72:92–99

    Article  PubMed  CAS  Google Scholar 

  3. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM (2005) Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 20:1638–1642

    Article  PubMed  Google Scholar 

  4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305

    Article  PubMed  CAS  Google Scholar 

  5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663

    Article  PubMed  Google Scholar 

  6. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V et al (2003) Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108:420–425

    Article  PubMed  CAS  Google Scholar 

  7. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, Thakur JS et al (2010) Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract 89:181–188

    Article  PubMed  Google Scholar 

  8. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V et al (2004) The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140:167–174

    PubMed  Google Scholar 

  9. Sun F, Tao Q, Zhan S (2010) Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort. Nephrology (Carlton) 15:84–92

    Article  CAS  Google Scholar 

  10. Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16:2134–2140

    Article  PubMed  Google Scholar 

  11. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS et al (2007) Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12:391–398

    Article  CAS  Google Scholar 

  12. Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K et al (2007) Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 30:937–943

    Article  PubMed  CAS  Google Scholar 

  13. Peralta CA, Kurella M, Lo JC, Chertow GM. The metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 15: 361–5

  14. Ford ES (2005) Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U. S. Diabetes Care 28:2745–2749

    Article  PubMed  Google Scholar 

  15. Chang IH, Han JH, Myung SC, Kwak KW, Kim TH, Park SW et al (2009) Association between metabolic syndrome and chronic kidney disease in the Korean population. Nephrology (Carlton) 14:321–326

    Article  Google Scholar 

  16. Miyatake N, Shikata K, Makino H, Numata T (2010) Relationship between estimated glomerular filtration rate (eGFR) and metabolic syndrome in Japanese. Acta Med Okayama 64:203–208

    PubMed  CAS  Google Scholar 

  17. Wang Q, Chen X, Zhao Y, Gao K, Sun YG, Yang M (2008) Association between metabolic syndrome and chronic kidney disease. Zhonghua Xin Xue Guan Bing Za Zhi 36:618–622

    PubMed  Google Scholar 

  18. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50–71 years old. N Engl J Med 355:763–778

    Article  PubMed  CAS  Google Scholar 

  19. Abbott KC, Glanton CW, Trespalacios FC, Oliver DK, Ortiz MI, Agodoa LY et al (2004) Body mass index, dialysis modality, and survival: analysis of the united states renal data system dialysis morbidity and mortality wave II study. Kidney Int 65:597–605

    Article  PubMed  Google Scholar 

  20. Chitalia N, Raja RB, Bhandara T, Agrawal P, Kaski JC, Jha V et al (2010) Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. J Nephrol 23:77–84

    PubMed  CAS  Google Scholar 

  21. Cheung CY, Chan HW, Liu YL, Chan YH, Wong HS, Chak WL et al (2008) Prevalence of metabolic syndrome in Chinese renal transplant recipients. Hong Kong Med J 14:379–384

    PubMed  CAS  Google Scholar 

  22. Naganuma T, Uchida J, Kinoshita Y, Kuroki Y, Takemoto Y, Yoshimura R et al (2007) The prevalence of metabolic syndrome in Japanese renal transplant recipients. Nephrology (Carlton) 12:413–417

    Article  Google Scholar 

Download references

Acknowledgements

This study was partly funded by student elective grants from British Renal Association and Kathleen Valles Trust

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debasish Banerjee.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banerjee, D., Chitalia, N., Raja, R. et al. Metabolic syndrome in chronic kidney disease and renal transplant patients in North India. Int Urol Nephrol 44, 937–943 (2012). https://doi.org/10.1007/s11255-011-9998-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-011-9998-6

Keywords

Navigation